Merck Joins CAR T-cell Market with $941 Million Intrexon Alliance
Merck Serono announces that it will work with Intrexon to develop a cancer therapy using chimeric antigen receptor T-cells.

Horizon Offers $1.1 Billion for Hyperion
Horizon Pharma offers to buy Hyperion Therapeutics for $1.1 billion in cash.

SHOWCASING MORE PHARMACEUTICAL AND BIOPHARMACEUTICAL INNOVATION, TECHNOLOGY, AND KNOWLEDGE
INTERPHEX 2015
April 21-23, 2015 l Javits Center, NY, NY

INTERPHEX, sponsored by PDA, is the premier pharmaceutical and biopharmaceutical full product development life cycle. It brings over 12,000 global pharmaceutical and biotechnology professionals together with 600+ suppliers through a unique combination of exhibition, education, workshops, partnering opportunities, and networking events.
RegisterToday for Free!

Novartis Inks $250 Million Alliance with Aduro
Novartis announced that it entered into a multiyear alliance with Aduro Biotech to develop cancer immunotherapies, offering up to $250 million in upfront payments and equity investments.

USP Establishes Elemental Impurities Implementation Dates
USP announces an implementation date of Jan. 1, 2018 for General Chapters <232> Elemental Impurities—Limits and <2232> Elemental Contaminants in Dietary Supplements.

The White House Responds to Superbug Threats
The White House confirmed that it would commit $1.2 billion to tackle the growing problem of antibiotic-resistant superbugs.

Hamburg Era Ends at FDA
Commissioner Margaret Hamburg discusses globalization challenges and the need for investment in regulatory science during her last weeks at the agency.

FDA Denies Amgen's Certification Petition in Biosimilar Patent Dance
Biosimilar applicants will not be required to hand over their biosimilar applications and manufacturing dossiers to innovator companies, determines FDA.

BMS Acquires Autoimmune Portfolio from Novo Nordisk
Bristol-Myers Squibb acquired an exclusive license for Novo Nordisk's discovery biologics research program.

Industry Responds to FDA Labeling Rule
Drug makers back alternative to FDA labeling update rule.

European Pharmacopoeia Commission Adopts New and Revised Texts
The commission adopts 24 new and 72 revised texts for inclusion in the European Pharmacopoeia.

German Pharmaceutical Market Set to Hit $65 Billion by 2020
Germany is a mature market with high healthcare expenditure and pharmaceutical production but future growth could be potentially hindered by cost-saving government policies.

Access to New Medicines Requires Transparency and Collaboration, Says WHO Report
The WHO report outlines possible policies that may help governments reduce the high prices of new medicines.